David Wang
Director/Board Member at BIOVAXYS TECHNOLOGY CORP.
Net worth: 92 540 $ as of 2024-04-29
David Wang active positions
Companies | Position | Start | End |
---|---|---|---|
BIOVAXYS TECHNOLOGY CORP. | Director/Board Member | - | - |
BioVaxys LLC
BioVaxys LLC BiotechnologyHealth Technology BioVaxys LLC is a clinical stage biotechnology company, which engages in the development of immunotherapeutic vaccines for antiviral and individualized cancer therapy. It focuses on multihaptenized autologous vaccine that will initially be developed and marketed for melanoma and ovarian cancer. The company was founded by James Passin, Kenneth Kovan and David Berd and is headquartered in New York, NY. | Director/Board Member | - | - |
Encounter Technology Ltd. | Chief Executive Officer | - | - |
Career history of David Wang
Former positions of David Wang
Companies | Position | Start | End |
---|---|---|---|
Beijing Century Medical | Chief Executive Officer | - | - |
Training of David Wang
University of International Business | Masters Business Admin |
Statistics
International
Canada | 3 |
United States | 2 |
China | 2 |
Operational
Director/Board Member | 2 |
Chief Executive Officer | 2 |
Masters Business Admin | 1 |
Sectoral
Non-Energy Minerals | 2 |
Health Technology | 2 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
BIOVAXYS TECHNOLOGY CORP. | Non-Energy Minerals |
Private companies | 3 |
---|---|
BioVaxys LLC
BioVaxys LLC BiotechnologyHealth Technology BioVaxys LLC is a clinical stage biotechnology company, which engages in the development of immunotherapeutic vaccines for antiviral and individualized cancer therapy. It focuses on multihaptenized autologous vaccine that will initially be developed and marketed for melanoma and ovarian cancer. The company was founded by James Passin, Kenneth Kovan and David Berd and is headquartered in New York, NY. | Health Technology |
Beijing Century Medical | |
Encounter Technology Ltd. |
- Stock Market
- Insiders
- David Wang
- Experience